Dr. Colin Phipps Diong

Haematology

Credentials	MBBChBAO (Ireland), MRCP (United Kingdom), FRCPath (United Kingdom)
Language	English, Chinese, Bahasa Indonesia, Malay
Background	Dr Colin Phipps Diong is a Consultant in Haematology specialising in lymphoma and blood cancers, and haematopoietic stem cell transplantation. He received his medical degree from the National University of Ireland in 2002 and subsequently completed Internal Medicine residency and specialist training in Haematology at Singapore General Hospital. He obtained his MRCP (UK) and FRCPath (UK) in 2006 and 2011, respectively. He was awarded the HMDP fellowship to pursue subspecialty training in Lymphoma and Bone Marrow Transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent ten years with the Department of Haematology at Singapore General Hospital. He was appointed Lymphoma Director in 2012 and helped build the lymphoma program, later becoming Lymphoma Lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous Pharmaceutical-sponsored and Investigator-initiated clinical trials that have allowed patients access to many novel treatments. Through Investigator-initiated trials, he designed treatment schema incorporating novel targeted agents and immunotherapies into current standard treatment to try overcome treatment-resistance. Some of his clinical trials are currently being conducted at multiple hospitals in Singapore. He is also heavily involved in Research Ethics and will soon chair one of the SingHealth Centralised Institutional Review Boards. Dr Phipps has also been actively involved in undergraduate and postgraduate training of young Doctors in Singapore, serving in many educator roles, including postgraduate mentor, Senior Lecturer with Yong Loo Lin School of Medicine, MBBS examiner, and Assistant Adjunct Professor with DUKE-NUS Graduate Medical School. He has authored more than thirty papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as Advisor to numerous regional and international Expert Panels and Education Programs.

Credentials

MBBChBAO (Ireland), MRCP (United Kingdom), FRCPath (United Kingdom)

Language

English, Chinese, Bahasa Indonesia, Malay

Background

Dr Colin Phipps Diong is a Consultant in Haematology specialising in lymphoma and blood cancers, and haematopoietic stem cell transplantation. He received his medical degree from the National University of Ireland in 2002 and subsequently completed Internal Medicine residency and specialist training in Haematology at Singapore General Hospital. He obtained his MRCP (UK) and FRCPath (UK) in 2006 and 2011, respectively. He was awarded the HMDP fellowship to pursue subspecialty training in Lymphoma and Bone Marrow Transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle.

Dr Phipps spent ten years with the Department of Haematology at Singapore General Hospital. He was appointed Lymphoma Director in 2012 and helped build the lymphoma program, later becoming Lymphoma Lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous Pharmaceutical-sponsored and Investigator-initiated clinical trials that have allowed patients access to many novel treatments. Through Investigator-initiated trials, he designed treatment schema incorporating novel targeted agents and immunotherapies into current standard treatment to try overcome treatment-resistance. Some of his clinical trials are currently being conducted at multiple hospitals in Singapore. He is also heavily involved in Research Ethics and will soon chair one of the SingHealth Centralised Institutional Review Boards.

Dr Phipps has also been actively involved in undergraduate and postgraduate training of young Doctors in Singapore, serving in many educator roles, including postgraduate mentor, Senior Lecturer with Yong Loo Lin School of Medicine, MBBS examiner, and Assistant Adjunct Professor with DUKE-NUS Graduate Medical School. He has authored more than thirty papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as Advisor to numerous regional and international Expert Panels and Education Programs.